Healthcare Sales & Marketing Network News: synthetic biology

Searching News Database: synthetic biology

HSMN NewsFeed - 3 Aug 2023
Kyverna Therapeutics Extends Series B Financing Round to $145 Million and Brings in New Investors
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 15 Feb 2023
Codagenix Announces Close of $25 million Extension of Series B
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 4 Jan 2023
Mantra Bio Raises $9 Million in Series A-2 Financing to Advance Development of Lead Targeted Exosome Therapeutics Program
Biopharmaceuticals Ophthalmology Venture Capital

HSMN NewsFeed - 14 Jun 2022
Anjarium Biosciences appoints Stephen Yoo, MD as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 1 Jun 2022
Codagenix Receives FDA Clearance of Investigational New Drug Application for Live-Attenuated, Intranasal RSV Vaccine Candidate CodaVax(TM)-RSV
Biopharmaceuticals FDA

HSMN NewsFeed - 7 Apr 2022
Sherlock Biosciences Appoints Karen Davies as Chief Development Officer
Diagnostics Personnel

HSMN NewsFeed - 10 Feb 2022
GentiBio Appoints Industry Veteran Chuck Silberstein as Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Jan 2022
Kyverna Therapeutics Closes $85 Million Series B Financing led by Northpond Ventures
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 27 Sep 2021
Synlogic Appoints Molly Harper as Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 15 Sep 2021
Kyverna Therapeutics Appoints Ian Clark as Chairman of the Board and Karen Walker as Chief Technology Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Sep 2021
ATP Announces $40 Million in Series A Funding for srRNA Therapeutics Trailblazer Replicate Bioscience
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 21 Jul 2021
Coave Therapeutics Closes �33 million ($39 million) Series B Financing to Develop its Gene Therapy Pipeline and Next-Generation Vectors based on its AAV-Ligand Conjugate Platform
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 23 Mar 2021
Emalex Biosciences Raises $35 Million in Series C Preferred Stock to Advance Tourette Syndrome and Stuttering Clinical Trials
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 6 Jan 2021
Myeloid Therapeutics Launches with Over $50 Million in Financing and Two Clinical Trials
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 7 Aug 2020
Lodo Therapeutics Acquires Conifer Point Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions Personnel

HSMN NewsFeed - 13 Jan 2020
Kyverna Therapeutics Secures $25 Million Series A Funding from Key Investors and Enters into Strategic Collaboration with Gilead Sciences
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 20 Dec 2019
Lodo Therapeutics Names Serial Biotech Entrepreneur Dale Pfost As CEO And Adds Top Industry Veterans To Leadership Team
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 30 Aug 2018
RootPath Raises $7 Million Seed Round led by Sequoia China to Accelerate Its Cancer Immunotherapy Programs
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 16 Aug 2018
Synthorx Appoints Immuno-Oncology Veteran Joseph Leveque, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Jul 2018
Synthorx Expands Leadership Team with Three Key Hires
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Jun 2018
New England Biolabs(R) Launches New NEBNext(R) Single Cell/Low Input RNA Library Prep Kit for Increased Transcript Detection with Ultra-low Input Amounts
Diagnostics Product Launch

HSMN NewsFeed - 30 Apr 2018
Synthorx Announces $63 Million Series C Financing to Advance a Pipeline of Synthorin(TM) Cytokines
Biopharmaceuticals Oncology Venture Capital

HSMN NewsFeed - 5 Mar 2018
Aridis Pharmaceuticals, Inc. Appoints Wolfgang Dummer, M.D., Ph.D., as Chief Medical Officer, and Mitchell H. Rosner, Ph.D. as Vice President of Quality
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 27 Feb 2018
Senti Biosciences Secures $53 Million Series A to Build the Future of Gene and Cell-Based Therapies
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 5 Dec 2017
Cocoon Biotech Appoints Dr. Annalisa Jenkins as Executive Chair of the Board
Biopharmaceuticals Drug Delivery Ophthalmology Personnel

HSMN NewsFeed - 27 Nov 2017
Laura Shawver, Ph.D., Appointed CEO of Synthorx
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Oct 2017
Illumina Ventures Closes $230 Million Fund
Biopharmaceuticals Personalized Medicine Venture Capital

HSMN NewsFeed - 26 Sep 2017
Eligo Bioscience Secures $20 Million Series A from Khosla Ventures and Seventure to Bring Precision Medicine to the Microbiome
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 14 Aug 2017
Synthorx Appoints Marcos Milla, Ph.D. as Senior Vice President of Research
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Jul 2017
DelMar Pharmaceuticals Appoints Saiid Zarrabian to the Board of Directors and Names Dr. Erich Mohr as Chairman
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 14 Jun 2017
Twist Bioscience Raises Additional $27 Million
Biopharmaceuticals Diagnostics Venture Capital

HSMN NewsFeed - 27 Mar 2017
Twist Bioscience Raises $33 Million
Biopharmaceuticals Diagnostics Venture Capital

HSMN NewsFeed - 16 Mar 2017
eGenesis Announces $38 Million Series A Financing, Led by Biomatics Capital and ARCH Venture Partners, to Solve Shortage of Organs for Donation
Regenerative Medicine Venture Capital

HSMN NewsFeed - 28 Feb 2017
Muse bio secures $23M Series B financing led by Venrock
Devices Venture Capital

HSMN NewsFeed - 19 Dec 2016
Fibrocell Announces Leadership Changes
Biopharmaceuticals Personnel

HSMN NewsFeed - 28 Nov 2016
Synthorx Appoints Patrick J. Doyle as Chief Business Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 8 Jun 2016
Ginkgo Bioworks Secures $100 Million Series C Investment
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 19 Jan 2016
Twist Bioscience Completes $61 Million Series D Financing And $20 Million Debt Facility
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 18 Jan 2016
Michael Martino Named President and Chief Executive Officer of HemaFlo Therapeutics
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 May 2015
Jose-Carlos Guti�rrez-Ramos, Ph.D. Joins Synlogic as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Nov 2014
Agilis Biotherapeutics Names Former Shire Executive Dr. Gregory Robinson as Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Jul 2014
Synlogic Secures $29.4 Million Series A Financing Led by Atlas Venture and New Enterprise Associates
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 14 Jul 2014
MYOS Corporation Appoints World Renowned Scientific Visionary and Entrepreneur, J. Craig Venter, Ph.D., to Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Jan 2014
Fibrocell Science Appoints Robert Sheroff, Vice President of Technical Operations
Biopharmaceuticals Regenerative Medicine Personnel

HSMN NewsFeed - 31 Dec 2013
Agilis Biotherapeutics Completes $8 Million Financing to Develop DNA-based Therapeutics for Rare Diseases
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 31 Dec 2013
George S. Zorich Named Chief Executive Officer of Agilis Biotherapeutics
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 Mar 2013
ZIOPHARM Terminates Development of Palifosfamide in Metastatic Soft Tissue Sarcoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 6 Sep 2011
ZIOPHARM Oncology Appoints Caesar J. Belbel as Executive Vice President, Chief Legal Officer and Secretary
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 15 Jul 2011
ZIOPHARM Oncology Appoints Hagop Youssoufian, M.Sc., M.D., as Executive Vice President and Chief Medical Officer
Biopharmaceuticals Oncology

HSMN NewsFeed - 6 Nov 2007
Sloning BioTechnology GmbH Raised EUR 4.7m in a First Closing of a Series E Equity Financing Round
Biopharmaceuticals Venture Capital

Return to NewsFeed

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.